MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ)
$10.82 0.24 (2.2684%)
Analysed MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) News Sources
MLTX Stock Extends Pullback After Biggest Rally In Over 6 Months Following Skin Disease Trial Data — A Look At The Latest Development
24-06-2026
stocktwits.com
Why MoonLake Immunotherapeutics Stock Wilted on Wednesday
25-06-2026
fool.com
How Investors May Respond To MoonLake Immunotherapeutics (MLTX) VELA Data And Upsized Follow-On Offering
25-06-2026
yahoo.com
MoonLake Immunotherapeutics (MLTX) Outlook Strengthens as Analysts See Major Opportunity in Hidradenitis Suppurativa
30-06-2026
yahoo.com
MoonLake Immunotherapeutics' CFO Sells 39K Shares
03-07-2026
fool.com
Wall Street Analysts See a 73.35% Upside in MOONLAKE IMMUNO (MLTX): Can the Stock Really Move This High?
31-07-2026
yahoo.com
MLTX Stock Under Pressure As Investors Await Psoriatic Arthritis Trial Data
03-08-2026
stocktwits.com
MoonLake’s Psoriatic Arthritis Drug Shows Promise In Phase 3 Trial – Retail Shrugs Off Premarket Slide, Says ‘Pipeline Is Intact’
10-08-2026
stocktwits.com
MLTX Stock On Track For Worst Week Since Last Fall As FDA Filing Date For Skin Disease Drug Draws Near
11-09-2026
stocktwits.com
MoonLake Immunotherapeutics Could Win FDA Approval for Sonelokimab by Year-End 2027, Wedbush Says
05-10-2026
yahoo.com
What is the current price of MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ)?
The current price of MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) is $10.82.
MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) since the previous trading day is $0.24.
MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) since the previous trading day is 2.2684%.
What is the most recent average sentiment score for MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ)?
The most recent average sentiment score for MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) is 54 out of 100.
What is the most recent average sentiment for MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ)?
The most recent sentiment for MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) is .
SEC-8K** Filing Available For MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.